TechRound is excited to announce the winners of our HealthTech44 2026!
TechRound is excited to announce the winners of the 2026 HealthTech44 campaign, celebrating the most exciting and innovative businesses in health and medical technology this year.
Founded in 2016, TechRound is the UK’s best-known and fastest-growing startup and tech news site. This is where decision-makers, investors and startups of all sizes and nature come to find out the latest developments and trends within the industry.
See The List
Top 44 – See Here >>
Top 40 – See Here >>
Top 30 – See Here >>
Top 20 – See Here >>
Top 10 – See Here >>
Who Ranked Number 1? – See Here >>
Feedback From The Judges
One of the most encouraging aspects of judging this year’s HealthTech44 competition was seeing how many founders were thinking beyond the technology itself. The strongest entries combined innovative technology with a clear understanding of the clinical problem they were solving and a credible pathway to bringing that solution into practice. That combination of innovation, evidence and a clear route to adoption made this an exceptionally strong field and was a reminder of just how much high-quality innovation is taking place across the sector. Congratulations to everyone who took part, and particularly to this year’s winners.
Head Judge 2026
Dr. Stuart Grant, Founder of Archetype MedTech
Judging this field reinforced how quickly healthtech is moving from point solutions toward trusted clinical infrastructure. The strongest entries did more than present an interesting idea: they addressed a meaningful care or workflow problem, showed evidence of execution, and designed around the realities of clinicians, patients, regulation, and deployment. I was particularly drawn to companies combining clinical usefulness with measurable traction, explainable AI, strong data foundations, or devices capable of improving access outside traditional care settings.
I deliberately did not rank companies based only on size, valuation, or fundraising. Several early-stage teams scored well because the problem was urgent, the founder insight was authentic, and the pathway to validation was credible. The main gap across weaker entries was not ambition, but proof—clear outcomes, regulatory strategy, differentiation, and evidence that the solution can work consistently in real healthcare environments.
Jeremy Lawson, Founder and CEO of Salynt Inc.
As an independent virtual CISO with a background in risk management, cybersecurity, and regulatory compliance, I prefer facts over marketing claims. For TechRound’s HealthTech44 2026, I ranked the submissions on five evidence-based dimensions: stated security maturity, AI claim substantiation, clinical validity, patient impact, and the team’s credibility. Companies that scored higher had provided named certifications, published benchmarks, regulatory clearance, quantified outcomes, and experienced clinical leaders named in their submission. By comparison, entries with visible AI instructions, placeholder content, or contradictory claims were disqualified, and submissions that were primarily unsubstantiated product marketing ranked poorly with me.
Kayne McGladrey, Independent Virtual CISO
The list of startups are amongst the top health tech companies in the world tackling the most challenging health problems with their impact able to improve healthcare outcomes around the world. With the current theme of AI helping to deliver great outcomes, I am glad to see many healthtech companies utilising and being AI-first.
Samuel Okwuada, Founder and CEO of Remedial Health
Judging this year’s HealthTech competition was an inspiring experience. The quality of the submissions reflected the incredible innovation happening across the healthcare sector, with companies tackling real-world challenges through technology. From advancements in remote patient monitoring to AI-driven diagnostics and neurological care, these solutions demonstrated both technical excellence and a clear understanding of the needs of patients and healthcare professionals. What stood out most was the focus on creating accessible, scalable technologies with the potential to make a meaningful impact. It was encouraging to see such a high standard of innovation, and I look forward to seeing how these companies continue to shape the future of healthcare.
Laliq Schuman, Reporter and SEO Executive at TechRound
Thank You To Our Judges
Head Judge 2026
Dr. Stuart Grant, Founder of Archetype MedTech
Dr. Stuart Grant is the Founder of Archetype MedTech, where he provides product development leadership to founders, investors, and MedTech companies, bringing innovative medical technologies to market.
Alongside Archetype, Stuart is Co-Founder of C-True Surgical, Product Development Leadership Advisor to the Science and Engineering Health Technologies Alliance (SEHTA) and a Product Development Mentor with the NHS Clinical Entrepreneur Programme. His work spans the UK, Europe, the US and APAC, including Australia, China, and India.
Before founding Archetype, Stuart spent 25 years with Johnson & Johnson MedTech, where he established and led the company’s Shanghai R&D Centre of Excellence. He is a Chartered Engineer, a Fellow of the Institution of Mechanical Engineers, holds a PhD in Medical Device Technology and Innovation, is a named inventor on multiple US medical device patents and is a regular speaker, mentor and contributor across the global MedTech sector.
Read more about Dr. Stuart Grant and what he’s looking out for in HealthTech44 entrants here.
Aline Gómez-Acebo Finat, CEO at ENIAX
Aline Gomez-Acebo Finat is a prominent tech operator, angel investor, and ecosystem builder specializing in deep tech, digital health, and venture capital. As the CEO of ENIAX, she scales a healthtech platform utilizing machine learning and natural language processing to manage data for nearly 100 million patients across 8 countries.
Committed to bridging the venture funding gap, she is also the Co-Founder of Calafia Iberia, the region’s first women-led angel investment syndicate. An Adjunct Professor at IE Business School with executive credentials from MIT, Stanford, and Harvard, Aline has received numerous awards like Top 100 Female Leader and EPIC award for her sustainability efforts in business.
Jeremy Lawson, Founder and CEO of Salynt Inc.
Jeremy Lawson is the Founder and CEO of Salynt Inc., a healthcare AI company developing advanced neuroimaging and clinical decision-support technologies that help clinicians better understand and treat complex neurological conditions. With over a decade of experience in artificial intelligence, data science, and technology innovation across the Department of Defense and Intelligence Community, he understands the intersection of healthcare, technology, and commercialization. Jeremy holds a Master’s in Data Science from The George Washington University and a Bachelor’s in Mathematics from Jackson State University.
Beyond his professional work, Jeremy is committed to mentorship, education, and community impact. He is a member of The National Alliance for Doctoral Studies in the Mathematical Sciences and previously served as President of the Maryland Black Caucus Foundation and Vice President of the International Black Firefighters Museum. He is passionate about empowering the next generation of innovators while advancing technologies that improve patient outcomes and clinical decision-making.
Jeremy enjoys cooking, playing the piano, traveling, and watching football in his spare time.
Kayne McGladrey, Independent Virtual CISO
Kayne McGladrey is an independent virtual CISO who helps SMBs and mid-market firms navigate compliance, AI regulation and cyber risk. Author of the upcoming book “Cyber Risk is a Myth,” and ranked number one globally for his cybersecurity and risk management expertise, Kayne bridges technical security with business outcomes.
Oren Hershkovitz, Chief Executive Officer and Enlivex
Oren Hershkovitz is the CEO at Enlivex (Nasdaq: ENLV), a quality longevity company advancing Allocetra, a clinical-stage immunotherapy targeting age-related osteoarthritis, alongside a prediction markets treasury strategy built around the RAIN protocol.
In 2025 the company reported $1.23 billion in net profit and received FDA clearance for a Phase 2b clinical trial in the same week. Oren is a pharmaceutical executive with over 20 years of experience leading clinical programs from early discovery through Phase III trials and has overseen more than $200 million in financing throughout his career. He holds a PhD in Immunology with distinction from Ben-Gurion University of the Negev.
Prior to joining Enlivex in 2019, Oren served as General Manager of OPKO Biologics, where he led the late-stage clinical development of Ngenla, a long-acting growth hormone co-developed with Pfizer that is now approved in more than 40 countries, including the United States, the European Union and Japan.
Samuel Okwuada, Founder and CEO of Remedial Health
Samuel Okwuada is the Founder and Chief Executive Officer of Remedial Health, a healthcare technology company focused on optimizing the pharmaceutical supply chain in Africa. Educated as a pharmacist with a Master’s degree in Pharmacy from the University of East Anglia, UK; he is also a self-taught software engineer who initially began writing code at age 14.
During his university studies, Okwuada established a track record as a serial entrepreneur by founding 3 distinct startup companies and successfully completing 2 corporate exits. Through his leadership at Remedial Health, he builds direct-to-retail distribution networks for medical and non-medical consumables to improve inventory affordability for independent pharmacies across the African continent. His platform directly addresses regional supply shortages and pricing inefficiencies within the traditional medical distribution model.
Okwuada remains focused on leveraging his dual expertise in software engineering and clinical pharmacy to modernize medicine access and healthcare logistics.
Laliq Schuman, Reporter and SEO Executive at TechRound
Laliq is an SEO Executive with experience writing optimised content for a wide range of clients. She specialises in creating SEO-driven blogs and on-site content that aligns with both search intent and brand voice. With a client base spanning multiple industries, Laliq brings a broad knowledge of tech and consumer-focused topics to her work. Her exposure to innovation-driven sectors has sparked a particular interest in how technology can support and improve healthcare.
